glycerophosphoethanolamine has been researched along with Liver Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Basu, SS; Blair, IA; Clarke-Katzenberg, RH; Darpolor, MM; Glickson, JD; Kaplan, DE; Nelson, DS; Worth, A | 1 |
Bell, JD; Cox, IJ; Foster, CS; Iles, RA; Menon, DK; Peden, CJ; Sargentoni, J; Urenjak, J; Watanapa, P | 1 |
2 other study(ies) available for glycerophosphoethanolamine and Liver Neoplasms
Article | Year |
---|---|
The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Aspartic Acid; Carbon Isotopes; Carcinoma, Hepatocellular; Cell Line, Tumor; Chromatography, Liquid; Humans; Lactic Acid; Liver; Liver Neoplasms; Magnetic Resonance Spectroscopy; Mass Spectrometry; Metabolic Networks and Pathways; Metabolomics; Middle Aged; Phosphates; Phosphatidylethanolamines; Principal Component Analysis; Succinic Acid; Transcriptome | 2014 |
A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver.
Topics: Biopsy; Ethanolamines; Humans; Liver; Liver Neoplasms; Magnetic Resonance Spectroscopy; Pancreatitis; Phosphatidylcholines; Phosphatidylethanolamines; Phosphorylcholine | 1993 |